CLASS II Device recall · Reported 22 Jun 2016 · FDA Enforcement Report

BioFlo Hybrid PICC with Endexo and Pasv Valve Technology recalled

Navilyst Medical, Inc., an AngioDyamics is recalling BioFlo Hybrid PICC with Endexo and Pasv Valve Technology, Mst-70 Kit, 6F-, Upn H965458970, distributed nationwide in the US. The recall was initiated on 14 Mar 2016 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesBatch/Lots: 4749414, 4766098, 4770315, 4776150 & 4790009. Use By Date Range 2016-05-31 to 2016-09-30
Quantity recalled275 units

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

Recall details

Recall number
Z-1988-2016
FDA event ID
73598
Recalling firm
Navilyst Medical, Inc., an AngioDyamics, Glens Falls, NY
Classification
Class II
Status
Terminated
Recall initiated
14 Mar 2016
FDA classified
14 Jun 2016
Reported
22 Jun 2016
Type
Voluntary: Firm initiated
Customers notified by
Letter
Reason category
Labeling Errors
Device type
Patient Monitors

Timeline

14 Mar 2016Recall initiated by company
14 Jun 2016Classified by FDA+92 days
22 Jun 2016Published in enforcement report+8 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

PICC catheters that contain valve(s) manufactured prior to July 15, 2014 lack a manufacturing specification change that reduces the incidence of hemolysis during blood sampling through the PICC catheter.

Product as listed by the FDA

BioFlo Hybrid PICC with ENDEXO and PASV Valve Technology, MST-70 Kit, 6F-55cm, UPN H965458970, Rx ONLY The Xcela PICC with PASV, Xcela Hybrid PICC with PASV, BioFlo PICC with PASV and BioFlo Hybrid PICC with PASV are indicated for short or long-term peripheral access to the central venous system for intravenous therapy, including but not limited to, the administration of fluids, medications and nutrients; the sampling of blood; and for power injection of contrast media. Non-valve lumens are indicated for central venous pressure monitoring

Where it was distributed

Worldwide Distribution US (Nationwide) Internationally to AU, GR, SE, SA, IN, CA, GB, BR, BE, NL, ES, KR, HK, AE, IT and ES.

Nationwide CaliforniaIndiana

Questions about this recall

Is BioFlo Hybrid PICC with Endexo and Pasv Valve Technology, Mst-70 Kit, 6F-, Upn H965458970 recalled?

Yes. Navilyst Medical, Inc., an AngioDyamics recalled BioFlo Hybrid PICC with Endexo and Pasv Valve Technology, Mst-70 Kit, 6F-, Upn H965458970 on 14 Mar 2016. The recall is Class II and its status is Terminated. Recall number Z-1988-2016.

Why was it recalled?

PICC catheters that contain valve(s) manufactured prior to July 15, 2014 lack a manufacturing specification change that reduces the incidence of hemolysis during blood sampling through the PICC catheter.

Which lots are affected?

Batch/Lots: 4749414, 4766098, 4770315, 4776150 & 4790009. Use By Date Range 2016-05-31 to 2016-09-30

Where was it sold?

Worldwide Distribution US (Nationwide) Internationally to AU, GR, SE, SA, IN, CA, GB, BR, BE, NL, ES, KR, HK, AE, IT and ES.

What should I do if I have it?

Stop using the device if the notice says to, and contact the manufacturer or your healthcare provider for the correction or replacement.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 21 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Navilyst Medical, Inc., an AngioDyamics

All 23

Other Patient Monitors recalls

All 1,013